---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-002316"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2026-04-16T23:59:59+00:00"
generated_at: "2026-05-15T05:46:23.192770+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health reports record FY2025 revenue $65.3M, up 20%; gross profit +83%, adjusted EPS improves 82%

## Summary
- Revenue $65.3M (+20% YoY); gross profit $7.9M (+83%); gross margin 12.1% (+418 bps).
- Adjusted EPS improved to ($0.12) from ($0.65) (+82%); adjusted EBITDA loss narrowed to $3.36M.
- Cash and equivalents $3.5M, up 10x from $0.3M; total assets $65.5M (+21%).
- CEO Greg Siokas increased ownership by 3.3M shares; secured $300M digital asset financing facility.
- Contract manufacturing deals for 12M+ units; Sky Premium Life 60 new SKUs; U.S. expansion with NOOR Collagen.

## SEC filing metadata
- accession: 0001477932-26-002316
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2026-04-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/0001477932-26-002316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-002316
- JSON: https://secwatch.observer/filing/0001477932-26-002316.json
- Plain text: https://secwatch.observer/filing/0001477932-26-002316.txt

## Key facts
- Earnings Releases
  Cosmos Health Inc. reported the full year ended December 31, 2025 results: revenue $65.27 million, net income ($19.14 million), EPS ($0.63).
  - Period: the full year ended December 31, 2025
  - Revenue: $65.27 million
  - Net income: ($19.14 million)
  - EPS: ($0.63)
  - Result: reported results
  source text: through Decahedron in the United Kingdom, and the global expansion of proprietary brands, including Sky Premium Life and C-Scrub. Key Metric FY 2025 FY 2024 Change (in $) Revenue 65,271,815 54,426,402 +20 % Gross Profit 7,895,575 4,311,323 +83 % Gross Margin 12.10 % 7.92 % +418 basis points Adjusted EBITDA (3,361,385 ) (3,438,975 ) 2% improvement Adjusted Net Income
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/0001477932-26-002316-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.